German government approves decree to ease measures for two categories

Germany's government cabinet agreed on Tuesday to ease restrictive measures for those who have taken both doses of the vaccine against Covid-19 or who have already passed the disease. German Justice Minister Christine Lambrecht confirmed the news. The minister said restrictions should be eased once they cannot [...]
Germany's government cabinet agreed on Tuesday to ease restrictive measures for those who have taken both doses of the vaccine against Covid-19 or who have already passed the disease. German Justice Minister Christine Lambrecht confirmed the news.
The minister said restrictions should be eased once they can no longer be justified. If the risk of spreading the virus is greatly reduced in people who are fully vaccinated and healed persons, this should be considered in size. We have now implemented this”, she said.
About 8 percent of Germany's population have received two doses of vaccine so far and over 28 percent only the first dose. With the expansion of the vaccine programme and with the drop in number of cases, the government hopes the measures imposed since November last year will leave soon, Reuters writes.
The decree adopted by the government must also be approved by both of the assembly rooms and could enter into force from this weekend, said Minister Lambrecht.
According to new changes, those who have received both doses of vaccines or who have been cured by Covid-19 will not need negative tests to go to stores, hairsman, or to visit tourist areas. They will also be expelled from the police hour at night and can hold private meetings without restrictions.
Doning special freedoms only to vaccinated persons is a problem. Some say this measure could increase social tensions at a time when not all Germans have had the opportunity to vaccinate.
Others, however, say that relief of the measures could be used as a stimulating measure to convince people to be vaccinated. According to one survey, only 72 percent of Germans want to take the vaccine against Covid-19.










